Cybin Announces Grant of Additional U.S. Patent in Support of Its Cyb003 Breakthrough Therapy Program for Major Depressive Disorder
Cybin宣佈授予額外的美國專利,以支持其Cyb003重度抑鬱症突破性療法計劃
Cybin Announces Grant of Additional U.S. Patent in Support of Its Cyb003 Breakthrough Therapy Program for Major Depressive Disorder
Cybin宣佈授予額外的美國專利,以支持其Cyb003重度抑鬱症突破性療法計劃
使用瀏覽器的分享功能,分享給你的好友吧